Drug intelligence / Profile preview

famzeretcel

Development stage
Phase 2
Lead developer
jCyte
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravitreal, Ophthalmic
01

Overview

Famzeretcel is an allogeneic cell therapy consisting of human retinal progenitor cells (hRPCs) expanded in vitro. It is primarily developed for the treatment of retinitis pigmentosa (RP), a degenerative retinal disease characterized by the progressive loss of photoreceptors. The therapy is designed to be administered via intravitreal or subretinal injection, where the progenitor cells function by secreting neurotrophic factors that rescue dying photoreceptors and potentially integrate into the retinal architecture to restore visual function. The program has been advanced by **jCyte** (as jCell) and **ReNeuron Group** (as ReN003), with jCyte focusing on a minimally invasive intravitreal delivery method that has reached Phase 2 clinical evaluation.

Brand names
jCell
Other names
human retinal progenitor cellshRPCfamzeretcelum

Beyond the preview

Go deeper on famzeretcel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on famzeretcel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call